LBA41 Nivolumab (nivo) ± ipilimumab (ipi) in pre-treated patients with advanced, refractory pulmonary or gastroenteropancreatic poorly differentiated neuroendocrine tumors (NECs) (GCO-001 NIPINEC)
N. Girard
,
J. Mazieres
,
J. Otto
,
H. Lena
,
C. Lepage
,
T. Egenod
,
D. Smith
,
J. Madelaine
,
L. Gérinière
,
F. El Hajbi
,
A. Ferru
,
C. Clément-Duchêne
,
A. Madroszyk
,
J. Desrame
,
F. Morin
,
A. Langlais
,
P. Michel
,
C. Louvet
,
V. Westeel
,
Thomas Walter
(1, 2, 3, 4)
N. Girard
- Function : Author
J. Mazieres
- Function : Author
J. Otto
- Function : Author
H. Lena
- Function : Author
C. Lepage
- Function : Author
T. Egenod
- Function : Author
D. Smith
- Function : Author
J. Madelaine
- Function : Author
L. Gérinière
- Function : Author
F. El Hajbi
- Function : Author
A. Ferru
- Function : Author
C. Clément-Duchêne
- Function : Author
A. Madroszyk
- Function : Author
J. Desrame
- Function : Author
F. Morin
- Function : Author
A. Langlais
- Function : Author
P. Michel
- Function : Author
C. Louvet
- Function : Author
V. Westeel
- Function : Author
Thomas Walter
- Function : Author
- PersonId : 766421
- IdHAL : thomas-walter01
- ORCID : 0000-0002-4199-4561